Live Web Chat: Answering Questions on New Lymphoma Treatments

0

Ann LaCasce, MD, a medical oncologist in the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program, answered a variety of questions about Hodgkin and non-Hodgkin lymphoma during a live web chat hosted by Dana-Farber last month.

The chat, which featured questions submitted by patients and live viewers, focused on new treatments for lymphoma. Some of the topics discussed included new drugs Ibrutinib and Brentuximab, use of umbilical cord stem cells, and treatments with genetically engineered T-cells.

“There are some questions we still have, but I think the work around T-cells is a very exciting area in lymphoma, and it’s going to have applications in other cancers as well,” LaCasce said.

View a video of the Dec. 18 web chat below. For more information on lymphoma, visit the Dana-Farber Adult Lymphoma Program website.

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Francisco Marty, MD, led major study showing significant advances in improving safety of donor stem cell transplant… https://t.co/ZcDUJEHy2R
Dana-Farber @danafarber
14 - Then number of cancers smoking is connected to. https://t.co/SlkTasrHdW https://t.co/TRzZUP7dZV
Dana-Farber @danafarber
New antiviral drug cuts cytomegalovirus infection & improves survival in donor stem cell transplant patients https://t.co/VD0t8crtuq

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.